Bellevue Life Sciences Acquisition Corp. - *W EXP 02/09/202 (BLACW)

Historical Portfolio Holders from Q1 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / *W EXP 02/09/202
Shares, excl. options Q3 2024
5.22M
Holdings value Q3 2024
$131K
Value change Q3 2024
+$17.4K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
24
Number of buys Q3 2024
3
Number of sells Q3 2024
-4
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 5.22M $131K +$17.4K $0.02 24
2024 Q2 3.15M $63.2K -$4.43K $0.02 21
2024 Q1 4.88M $103K -$5.06K $0.02 27
2023 Q4 5.17M $101K -$12.2K $0.02 28
2023 Q3 4.91M $228K +$42.8K $0.05 24
2023 Q2 4.43M $348K +$114K $0.08 25
2023 Q1 3.12M $3.34M +$3.34M $0.07 16